NCT06982092View on ClinicalTrials.gov

Using Diaphragm Ultrasonography, Sugammadex Recovers Diaphragmatic Function More Effectively Than Neostigmine.

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 26, 2024

Primary Completion Date

January 15, 2025

Study Completion Date

January 15, 2025

Conditions
Perioperative Diaphragmatic Function
Interventions
DRUG

sugammadex

: patients will receive the reversal drug according to the group to which they had been randomised. in the Sugammadex Group will receive 2 mg/kg sugammadex.

DRUG

Neostigmine

Patients in the NEO Group will receive 50 mic/kg neostigmine and .01-.02 mg/kg atropine

Trial Locations (1)

Unknown

faculty of medicine, ain shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06982092 - Using Diaphragm Ultrasonography, Sugammadex Recovers Diaphragmatic Function More Effectively Than Neostigmine. | Biotech Hunter | Biotech Hunter